Literature DB >> 3396498

Effects of cyclosporine on the hypothalamic-pituitary-gonadal axis in the male rat: mechanism of action.

S C Sikka1, S Bhasin, D C Coy, M A Koyle, R S Swerdloff, J Rajfer.   

Abstract

In the intact adult male rat, cyclosporine (CsA) induces a significant decrease in serum testosterone (T), serum LH, and intratesticular T. To elucidate the mechanism of action of this CsA-induced hypogonadotropic hypogonadism, castrated male rats were treated with oral CsA (30 mg/kg.day) or vehicle alone, and serum LH was measured after 1, 2, and 4 weeks of treatment. Surprisingly, serum LH was higher in these CsA-treated castrated rats at 1, 2, and 4 weeks than in castrated controls. To provide insight into the cause of this increase in serum LH, a T implant (8 mm) was inserted (at week 5 of treatment) in both CsA-treated and control castrated animals, and serum LH was measured 1 week after insertion of the T implant. Serum LH levels decreased to control values after insertion of the T implant. Subsequently, two other groups of rats received 8-mm T implant at the time of castration and were then treated up to 4 weeks with either CsA or vehicle alone. Serum LH showed a significant decrease in these CsA- plus T-treated animals compared to the vehicle- plus T-treated animals. A GnRH stimulation test performed after 2 weeks of CsA/vehicle treatment showed a significant increase in serum LH in all the rats 30 min after GnRH administration (1, 10, 30, and 100 ng/100 g BW, ip), indicating a normal pituitary response. The increase in LH after exogenous GnRH treatment was more significant in CsA-treated intact rats than in the controls. There was no difference in creatinine clearance between intact and castrate T-treated rats regardless of whether they received CsA. These studies indicate that the hypogonadotropic hypogonadism induced by CsA in intact male rats is mediated through the hypothalamic-pituitary axis, primarily at its hypothalamus end, does not seem to be due to the nephrotoxicity of CsA, and is modulated by T and/or its metabolites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396498     DOI: 10.1210/endo-123-2-1069

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog.

Authors:  Chul Park; Jong-Hyun Yoo; Ha-Jung Kim; Chae-Young Lim; Ju-Won Kim; So-Young Lee; Jung-Hyun Kim; Jae-Im Jang; Hee-Myung Park
Journal:  Can Vet J       Date:  2010-11       Impact factor: 1.008

Review 2.  Male hypogonadism in cirrhosis and after liver transplantation.

Authors:  C Foresta; M Schipilliti; F A Ciarleglio; A Lenzi; D D'Amico
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

3.  Serum testosterone levels after cardiac transplantation.

Authors:  Jessica Fleischer; Donald J McMahon; Wylie Hembree; Vicki Addesso; Christopher Longcope; Elizabeth Shane
Journal:  Transplantation       Date:  2008-03-27       Impact factor: 4.939

4.  Cyclosporine is angiostatic.

Authors:  K Norrby
Journal:  Experientia       Date:  1992-12-01

Review 5.  Endocrine and metabolic abnormalities following kidney transplantation.

Authors:  W H Hörl; W Riegel; C Wanner; M Haag-Weber; P Schollmeyer; H Wieland; H Wilms
Journal:  Klin Wochenschr       Date:  1989-09-01

6.  Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4.

Authors:  P A Kelly; H Wang; K L Napoli; B D Kahan; H W Strobel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Oct-Dec       Impact factor: 2.569

7.  Endocrine disorders after heart transplantation: national cohort study.

Authors:  Matej Rakusa; Bojan Vrtovec; Gregor Poglajen; Andrej Janez; Mojca Jensterle
Journal:  BMC Endocr Disord       Date:  2020-04-20       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.